Vinay Saini

About

About Research:
Research areas: TB Therapeutics, TB Diagnostics and Child Malnutrition (0-6 years). In TB Therapeutics Project (India Health Fund, TATA TRUST), team members have been working on developing inhalation therapy (formulations) against MDR TB. In TB Diagnostics project (IMPRINT INDIA: MHRD & MHFW), we are working on low cost, affordable TB diagnostics in co-ordination with ICMR labs, Pharma/ Biotech companies, TB hospitals, RNTCP Lab, European and US organizations. In other areas, I have been working on geospatial mapping of child malnutrition for generation of real time data (WHO Anthropometric Parameters: Wasting, Stunting and Underweight, BMI) and relevamt interventions for child malnutrition. I worked on microparticulate vaccine delivery for Hepatitis B (M.Pharma: Pharmaceutical Biotechnology) and Filariais (Ph.D. in pharmaceutical Sciences). Recently, I have started my own start up for promoting translational research in Pharma, Biotech and Neutraceutical sector.

Research Interests:
TB Diagnostics (urine, sputum and serum), TB Therapeutics (Drug Resistance) & Malnutrition (real time data and interventions), Formulations for MRSA & VRE infections, Mosquito repellent formulations, Vaccine research (adjuvants).

I have been working on Rapid Covid-19 antigen and antibody tests through my startup (www.patanjalipharma.com) and soon they will be commercialized after internal validation.

Employment

• Foundation for TB, Malnutrition and AIDS (TUMAAS) Director
  2019 - Present
• Indian Institute of Technology Bombay Senior Scientist (Out Standing)
  2017 - Present
• Patanjali Pharma Pvt Ltd, SINE IIT Bombay Director
  2015 - Present
• Indian Institute of Technology Bombay Institute Post Doc Fellow
  2014 - 2017
• Indian Institute of Technology Bombay Research Associate
  2014 - 2014
• S.D.College of Pharmacy, Associate Professor
  2012 - 2013
• Dr Hari Singh Gour University Guest Faculty Member
  2010 - 2012
• Institute of Pharmacy Lecturer
  2007 - 2008

Education

• Swiss Federal Institute of Technology (ETH) Post Doctorate Fellow
  2013 - 2013
• Dr Hari Singh Gour University Ph.D. (Pharmaceutical Sciences)
  2008 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Humoral and cell-mediated immune responses elicited by poly (dl-lactide) adjuvanted filarial antigen molecules
  Drug Delivery 2014 DOI: 10.3109/10717544.2013.848494
  +Save
• Development and Characterization of Nanoparticles for the Delivery of Gemcitabine Hydrochloride
  The Scientific World Journal 2014 DOI: 10.1155/2014/560962
  +Save
• Development and Characterization ofIn SituOral Gel of Spiramycin
  BioMed Research International 2014 DOI: 10.1155/2014/876182
  +Save
• Edible Transgenic Plant Vaccines for Different Diseases
  Current Pharmaceutical Biotechnology 2013 DOI: 10.2174/138920101131400225
  +Save
• Poly(d,l)-lactide-co-glycolide (PLGA) microspheres as immunoadjuvant for Brugia malayi antigens
  Vaccine 2013 DOI: 10.1016/j.vaccine.2013.06.066
  +Save
• Sufficiency of a single administration of filarial antigens adsorbed on polymeric lamellar substrate particles of poly (l-lactide) for immunization
  International Journal of Pharmaceutics 2011 DOI: 10.1016/j.ijpharm.2011.08.005
  +Save
• Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen
  International Journal of Pharmaceutics 2011 DOI: 10.1016/j.ijpharm.2011.01.045
  +Save
• Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres
  Journal of Drug Targeting 2010 DOI: 10.3109/10611860903386920
  +Save
• Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine
  Vaccine 2009 DOI: 10.1016/j.vaccine.2009.02.023
  +Save